Abstract
Congenital urinary tract obstruction is an important cause of renal disease in children. Early animal studies have shown a relationship between the timing of obstruction and the different pathological entities that collectively comprise renal maldevelopment. A multitude of molecular factors through both in-vivo and in-vitro studies have been identified that are involved in apoptosis and/or interstitial fibrosis as a result of urinary tract obstruction. These molecular factors have been found to work in parallel and also occasionally divergent pathways. Apoptosis is a prominent feature of early in-utero urinary tract obstruction and a major factor in the loss of renal mass and renal dysfunction. Furthermore, there is an increasing body of evidence to suggest that apoptosis is an inciting event in the development of progressive interstitial fibrosis which further contributes to renal demise. Clearly, a better understanding of the mechanisms of apoptosis and the subsequent development of targeted therapies directed against apoptosis may prove beneficial in the prevention of renal dysfunction associated with urinary tract obstruction.
Keywords: Apoptosis, interstitial fibrosis, obstruction, nephropathy, cystic dysplasia, hydronephrosis, renal tubular cells, Osteopontin, Angiotensin II, urinary tract
Current Pediatric Reviews
Title: Apoptosis in Obstructive Nephropathy
Volume: 7 Issue: 4
Author(s): Ethan I. Franke and Kirstan K. Meldrum
Affiliation:
Keywords: Apoptosis, interstitial fibrosis, obstruction, nephropathy, cystic dysplasia, hydronephrosis, renal tubular cells, Osteopontin, Angiotensin II, urinary tract
Abstract: Congenital urinary tract obstruction is an important cause of renal disease in children. Early animal studies have shown a relationship between the timing of obstruction and the different pathological entities that collectively comprise renal maldevelopment. A multitude of molecular factors through both in-vivo and in-vitro studies have been identified that are involved in apoptosis and/or interstitial fibrosis as a result of urinary tract obstruction. These molecular factors have been found to work in parallel and also occasionally divergent pathways. Apoptosis is a prominent feature of early in-utero urinary tract obstruction and a major factor in the loss of renal mass and renal dysfunction. Furthermore, there is an increasing body of evidence to suggest that apoptosis is an inciting event in the development of progressive interstitial fibrosis which further contributes to renal demise. Clearly, a better understanding of the mechanisms of apoptosis and the subsequent development of targeted therapies directed against apoptosis may prove beneficial in the prevention of renal dysfunction associated with urinary tract obstruction.
Export Options
About this article
Cite this article as:
I. Franke Ethan and K. Meldrum Kirstan, Apoptosis in Obstructive Nephropathy, Current Pediatric Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339611796892346
DOI https://dx.doi.org/10.2174/157339611796892346 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Poly(ADP-ribosylation) and Neoplastic Transformation: Effect of PARP Inhibitors
Current Pharmaceutical Biotechnology Natural Steroids and Androgen Antagonists used as Neuroprotection in Common Neurological Disorders
CNS & Neurological Disorders - Drug Targets SRC: Regulation, Role in Human Carcinogenesis and Pharmacological Inhibitors
Current Pharmaceutical Design Synthesis and Biological Activity of New 4β-N-Heteroaryl Analogues of Podophyllotoxin
Letters in Drug Design & Discovery Synthesis, 17α-hydroxylase-C17,20-lyase Inhibitory and 5AR Reductase Activity of Novel Pregnenolone Derivatives
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs in Platelet Biogenesis and Function: Implications in Vascular Homeostasis and Inflammation
Current Vascular Pharmacology Angiogenesis Inhibition: State of the Art, Forgotten Strategies and New Perspectives in Cancer Therapy
Current Cancer Therapy Reviews Microenvironmental Interactions in Chronic Lymphocytic Leukemia: Hints for Pathogenesis and Identification of Targets for Rational Therapy
Current Pharmaceutical Design Editorial [Hot topic: Hepatocyte Growth Factor and cMET, New Development in Cancer Therapies (Guest Editors: T.A. Martin and W.G. Jiang)]
Anti-Cancer Agents in Medicinal Chemistry Epidermal Growth Factor Receptor and its Trafficking Regulation by Acetylation: Implication in Resistance and Exploring the Newer Therapeutic Avenues in Cancer
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Antitumor Titanium Compounds
Mini-Reviews in Medicinal Chemistry 3D-QSAR and Docking Studies on 2-acyliminobenzimidazoles Derivatives as Potent ALK Inhibitors
Letters in Drug Design & Discovery Procyanidin B2 3,3″-di-O-gallate Inhibits Endothelial Cells Growth and Motility by Targeting VEGFR2 and Integrin Signaling Pathways
Current Cancer Drug Targets Editorial (Thematic Issue: Targeting Mammalian Spermatogenesis: A Matter of Support)
Current Molecular Pharmacology Tetraplex Binding Molecules as Anti-Cancer Agents
Recent Patents on Anti-Cancer Drug Discovery Peripartum Cardiomyopathy: Current State of Knowledge, New Developments and Future Directions
Current Cardiology Reviews Ovarian Toxicity: From Environmental Exposure to Chemotherapy
Current Pharmaceutical Design Antineoplastic Activity of Monocrotaline Against Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Cell Cycle Control by the CDC25 Phosphatases
Anti-Cancer Agents in Medicinal Chemistry